These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25311677)

  • 21. Female urinary incontinence: effective treatment strategies.
    Castro RA; Arruda RM; Bortolini MA
    Climacteric; 2015 Apr; 18(2):135-41. PubMed ID: 25307986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overactive Bladder.
    White N; Iglesia CB
    Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity: J. H. Choe, M. S. Choo and K. S. Lee. J Urol 2008; 179: 214-219.
    Rosier PF
    J Urol; 2008 Nov; 180(5):2259-60. PubMed ID: 18804818
    [No Abstract]   [Full Text] [Related]  

  • 24. Urodynamics in pelvic organ prolapse: when are they helpful and how do we use them?
    Ballert KN
    Urol Clin North Am; 2014 Aug; 41(3):409-17, viii. PubMed ID: 25063597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder/detrusor overactivity? ICI-RS 2017.
    Malde S; Fry C; Schurch B; Marcelissen T; Averbeck M; Digesu A; Sahai A
    Neurourol Urodyn; 2018 Jun; 37(S4):S108-S116. PubMed ID: 30133790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of preoperative urodynamics for clinical diagnosis of female patients with stress urinary incontinence].
    Zhang WY; Hu H; Wang Q; Chen JW; Xu KX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):655-658. PubMed ID: 29263507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OnabotulinumtoxinA detrusor injection improves female sexual function in women with overactive bladder wet syndrome.
    Balzarro M; Rubilotta E; Braga A; Bassi S; Processali T; Artibani W; Serati M
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():228-231. PubMed ID: 29753213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder dysfunction does not affect long-term success rate of the retropubic suburethral sling procedure in women with stress urinary incontinence.
    Ong HL; Kuo HC
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O168-O173. PubMed ID: 30484955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of transobturator tape treatment on overactive bladder symptoms, particularly nocturia, in patients with mixed urinary incontinence.
    Lee SK; Kang HW; Kim WT; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2014 Aug; 55(8):520-6. PubMed ID: 25132946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update in the treatment of male urinary incontinence.
    Bing MT; Uhlman MA; Kreder KJ
    Curr Opin Urol; 2013 Nov; 23(6):540-4. PubMed ID: 23945475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of urodynamics in the treatment of mixed urinary incontinence in women with suburethral slings].
    Salinas-Casado J; Méndez-Rubio S; Pesquera-Ortega L; Vírseda-Chamorro M; Gutiérrez-Martín P; Resel-Folkersma L; Esteban-Fuertes M; Moreno-Sierra J
    Arch Esp Urol; 2016 May; 69(4):172-7. PubMed ID: 27225054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life and objective outcome assessment in women with tape division after surgery for stress urinary incontinence.
    Ulrich D; Bjelic-Radisic V; Höllein A; Trutnovsky G; Tamussino K; Aigmüller T
    PLoS One; 2017; 12(3):e0174628. PubMed ID: 28346541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin (OnabotulinumtoxinA) in the male non-neurogenic overactive bladder: clinical and quality of life outcomes.
    Habashy D; Losco G; Tse V; Collins R; Chan L
    BJU Int; 2015 Oct; 116 Suppl 3():61-5. PubMed ID: 26176660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications Following the Insertion of Two Synthetic Mid-urethral Slings and Subsequent Removal.
    Lee D; Bacsu C; Dillon B; Zimmern PE
    Low Urin Tract Symptoms; 2018 Sep; 10(3):259-265. PubMed ID: 28657139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.
    Marcelissen T; Van Kerrebroeck P
    Neurourol Urodyn; 2018 Jan; 37(1):83-88. PubMed ID: 28631830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traditional suburethral sling operations for urinary incontinence in women.
    Rehman H; Bezerra CC; Bruschini H; Cody JD
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001754. PubMed ID: 21249648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
    Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
    J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.
    Kennelly M; Dmochowski R; Schulte-Baukloh H; Ethans K; Del Popolo G; Moore C; Jenkins B; Guard S; Zheng Y; Karsenty G;
    Neurourol Urodyn; 2017 Feb; 36(2):368-375. PubMed ID: 26607743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
    Chughtai B; Dunphy C; Lee R; Lee D; Sheth S; Marks L; Kaplan SA; Te AE
    Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary disorders and female sexual function.
    Chen J; Sweet G; Shindel A
    Curr Urol Rep; 2013 Aug; 14(4):298-308. PubMed ID: 23716031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.